Novel synthetic clot analogs for in-vitro stroke modelling

Standard

Novel synthetic clot analogs for in-vitro stroke modelling. / Guerreiro, Helena; Wortmann, Nadine; Andersek, Thomas; Ngo, Tuan N; Frölich, Andreas M; Krause, Dieter; Fiehler, Jens; Kyselyova, Anna A; Flottmann, Fabian.

In: PLOS ONE, Vol. 17, No. 9, e0274211, 2022.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{85f000557adb410eb6d0e5817447429d,
title = "Novel synthetic clot analogs for in-vitro stroke modelling",
abstract = "PURPOSE: The increased demand for training of mechanical thrombectomy in ischemic stroke and development of new recanalization devices urges the creation of new simulation models both for training and device assessment. Clots properties have shown to play a role in procedural planning and thrombectomy device effectiveness. In this study, we analyzed the characteristics and applicability of completely synthetic, animal-free clots in the setting of an in-vitro model of mechanical thrombectomy for training and device assessment.METHODS: Synthetic clots based on agarose (n = 12) and silicone (n = 11) were evaluated in an in-vitro neurointervention simulation of mechanical thrombectomy with clot extraction devices. Calcified clots of mixed nature were simulated with addition of 3D printed structures. 9 clots were excluded due to insufficient vessel occlusion and failure to integrate with clot extraction device. Synthetic thrombi were characterized and compared using a categorical score-system on vessel occlusion, elasticity, fragmentation, adherence and device integration.RESULTS: Both agarose-based and silicone-based clots demonstrated relevant flow arrest and a good integration with the clot extraction device. Silicone-based clots scored higher on adherence to the vessel wall and elasticity.CONCLUSION: Selected synthetic clots can successfully be implemented in an in-vitro training environment of mechanical thrombectomy. The clots' different properties might serve to mimic fibrin-rich and red blood cell-rich human thrombi.",
keywords = "Humans, Sepharose, Silicones, Stroke/therapy, Thrombectomy, Thrombosis, Treatment Outcome",
author = "Helena Guerreiro and Nadine Wortmann and Thomas Andersek and Ngo, {Tuan N} and Fr{\"o}lich, {Andreas M} and Dieter Krause and Jens Fiehler and Kyselyova, {Anna A} and Fabian Flottmann",
year = "2022",
doi = "10.1371/journal.pone.0274211",
language = "English",
volume = "17",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

RIS

TY - JOUR

T1 - Novel synthetic clot analogs for in-vitro stroke modelling

AU - Guerreiro, Helena

AU - Wortmann, Nadine

AU - Andersek, Thomas

AU - Ngo, Tuan N

AU - Frölich, Andreas M

AU - Krause, Dieter

AU - Fiehler, Jens

AU - Kyselyova, Anna A

AU - Flottmann, Fabian

PY - 2022

Y1 - 2022

N2 - PURPOSE: The increased demand for training of mechanical thrombectomy in ischemic stroke and development of new recanalization devices urges the creation of new simulation models both for training and device assessment. Clots properties have shown to play a role in procedural planning and thrombectomy device effectiveness. In this study, we analyzed the characteristics and applicability of completely synthetic, animal-free clots in the setting of an in-vitro model of mechanical thrombectomy for training and device assessment.METHODS: Synthetic clots based on agarose (n = 12) and silicone (n = 11) were evaluated in an in-vitro neurointervention simulation of mechanical thrombectomy with clot extraction devices. Calcified clots of mixed nature were simulated with addition of 3D printed structures. 9 clots were excluded due to insufficient vessel occlusion and failure to integrate with clot extraction device. Synthetic thrombi were characterized and compared using a categorical score-system on vessel occlusion, elasticity, fragmentation, adherence and device integration.RESULTS: Both agarose-based and silicone-based clots demonstrated relevant flow arrest and a good integration with the clot extraction device. Silicone-based clots scored higher on adherence to the vessel wall and elasticity.CONCLUSION: Selected synthetic clots can successfully be implemented in an in-vitro training environment of mechanical thrombectomy. The clots' different properties might serve to mimic fibrin-rich and red blood cell-rich human thrombi.

AB - PURPOSE: The increased demand for training of mechanical thrombectomy in ischemic stroke and development of new recanalization devices urges the creation of new simulation models both for training and device assessment. Clots properties have shown to play a role in procedural planning and thrombectomy device effectiveness. In this study, we analyzed the characteristics and applicability of completely synthetic, animal-free clots in the setting of an in-vitro model of mechanical thrombectomy for training and device assessment.METHODS: Synthetic clots based on agarose (n = 12) and silicone (n = 11) were evaluated in an in-vitro neurointervention simulation of mechanical thrombectomy with clot extraction devices. Calcified clots of mixed nature were simulated with addition of 3D printed structures. 9 clots were excluded due to insufficient vessel occlusion and failure to integrate with clot extraction device. Synthetic thrombi were characterized and compared using a categorical score-system on vessel occlusion, elasticity, fragmentation, adherence and device integration.RESULTS: Both agarose-based and silicone-based clots demonstrated relevant flow arrest and a good integration with the clot extraction device. Silicone-based clots scored higher on adherence to the vessel wall and elasticity.CONCLUSION: Selected synthetic clots can successfully be implemented in an in-vitro training environment of mechanical thrombectomy. The clots' different properties might serve to mimic fibrin-rich and red blood cell-rich human thrombi.

KW - Humans

KW - Sepharose

KW - Silicones

KW - Stroke/therapy

KW - Thrombectomy

KW - Thrombosis

KW - Treatment Outcome

U2 - 10.1371/journal.pone.0274211

DO - 10.1371/journal.pone.0274211

M3 - SCORING: Journal article

C2 - 36083986

VL - 17

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 9

M1 - e0274211

ER -